Clinical Trials Logo

Chagas' Disease (Chronic) Nos clinical trials

View clinical trials related to Chagas' Disease (Chronic) Nos.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03587766 Completed - Clinical trials for Chagas' Disease (Chronic) Nos

Oral Fexinidazole Dosing Regimens for the Treatment of Adults With Chronic Indeterminate Chagas Disease

FEXI12
Start date: November 13, 2017
Phase: Phase 2
Study type: Interventional

This study focuses on the evaluation of low doses (600 and 1200 mg) and short treatment duration (at 3, 7 and 10 days) of fexinidazole (Fexi) to determine the minimal efficacious and safe dose for the treatment of adult patients with chronic indeterminate Chagas Disease (CD).